Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine

The aim of this paper is to report the first case of atomoxetine leading to false-positive urine drug screen. An otherwise healthy 27-year-old female with a history of attention deficit hyperactivity disorder (ADHD) treated with atomoxetine had an acute onset tonic-clonic seizure. On arrival to the...

Full description

Saved in:
Bibliographic Details
Main Authors: Joshua L. Fenderson, Amy N. Stratton, Jennifer S. Domingo, Gerald O. Matthews, Christopher D. Tan
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Case Reports in Psychiatry
Online Access:http://dx.doi.org/10.1155/2013/381261
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562490043531264
author Joshua L. Fenderson
Amy N. Stratton
Jennifer S. Domingo
Gerald O. Matthews
Christopher D. Tan
author_facet Joshua L. Fenderson
Amy N. Stratton
Jennifer S. Domingo
Gerald O. Matthews
Christopher D. Tan
author_sort Joshua L. Fenderson
collection DOAJ
description The aim of this paper is to report the first case of atomoxetine leading to false-positive urine drug screen. An otherwise healthy 27-year-old female with a history of attention deficit hyperactivity disorder (ADHD) treated with atomoxetine had an acute onset tonic-clonic seizure. On arrival to the hospital, a urine toxicological drug screen with immunochemical cloned enzyme donor immunoassay (CEDIA) was performed. Results were positive for amphetamines; however, the presence of these substances could not be confirmed with urine gas chromatography-mass spectrometry (GC-MS). She denied any illicit drug use, herbal medications, or supplements, and her other prescription medications have not been previously known to cause a false-positive result for amphetamines. While stimulant treatments for ADHD could certainly result in a positive result on urine screen for amphetamines, there have been no reports of false-positive results for amphetamines secondary to patients using atomoxetine. We implicate atomoxetine, and/or its metabolites, as a compound or compounds which may interfere with urine drug immunoassays leading to false-positive results for amphetamines CEDIA assays.
format Article
id doaj-art-a2b03442ca344527943daca7cba958af
institution Kabale University
issn 2090-682X
2090-6838
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Case Reports in Psychiatry
spelling doaj-art-a2b03442ca344527943daca7cba958af2025-02-03T01:22:35ZengWileyCase Reports in Psychiatry2090-682X2090-68382013-01-01201310.1155/2013/381261381261Amphetamine Positive Urine Toxicology Screen Secondary to AtomoxetineJoshua L. Fenderson0Amy N. Stratton1Jennifer S. Domingo2Gerald O. Matthews3Christopher D. Tan4Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USADepartment of Internal Medicine, Tripler Army Medical Center, 1 Jarrett White Road, Honolulu, HI 96859-5000, USADepartment of Psychiatry, Tripler Army Medical Center, 1 Jarrett White Road, Honolulu, HI 96859-5000, USADepartment of Psychiatry, Tripler Army Medical Center, 1 Jarrett White Road, Honolulu, HI 96859-5000, USADepartment of Pharmacy, Tripler Army Medical Center, 1 Jarrett White Road, Honolulu, HI 96859-5000, USAThe aim of this paper is to report the first case of atomoxetine leading to false-positive urine drug screen. An otherwise healthy 27-year-old female with a history of attention deficit hyperactivity disorder (ADHD) treated with atomoxetine had an acute onset tonic-clonic seizure. On arrival to the hospital, a urine toxicological drug screen with immunochemical cloned enzyme donor immunoassay (CEDIA) was performed. Results were positive for amphetamines; however, the presence of these substances could not be confirmed with urine gas chromatography-mass spectrometry (GC-MS). She denied any illicit drug use, herbal medications, or supplements, and her other prescription medications have not been previously known to cause a false-positive result for amphetamines. While stimulant treatments for ADHD could certainly result in a positive result on urine screen for amphetamines, there have been no reports of false-positive results for amphetamines secondary to patients using atomoxetine. We implicate atomoxetine, and/or its metabolites, as a compound or compounds which may interfere with urine drug immunoassays leading to false-positive results for amphetamines CEDIA assays.http://dx.doi.org/10.1155/2013/381261
spellingShingle Joshua L. Fenderson
Amy N. Stratton
Jennifer S. Domingo
Gerald O. Matthews
Christopher D. Tan
Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
Case Reports in Psychiatry
title Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
title_full Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
title_fullStr Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
title_full_unstemmed Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
title_short Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
title_sort amphetamine positive urine toxicology screen secondary to atomoxetine
url http://dx.doi.org/10.1155/2013/381261
work_keys_str_mv AT joshualfenderson amphetaminepositiveurinetoxicologyscreensecondarytoatomoxetine
AT amynstratton amphetaminepositiveurinetoxicologyscreensecondarytoatomoxetine
AT jennifersdomingo amphetaminepositiveurinetoxicologyscreensecondarytoatomoxetine
AT geraldomatthews amphetaminepositiveurinetoxicologyscreensecondarytoatomoxetine
AT christopherdtan amphetaminepositiveurinetoxicologyscreensecondarytoatomoxetine